VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Affinavix

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 28 out of 100

Also known as Affinivax

  • Biotech & therapeutics
Status
Acquiredas of 2026-09-18Source (opens in a new tab)
Business model
B2B
Claim, correct or request removal

Record updated 28 September 2026

About

Affinivax was aqcuired by GSK in August 2022. Pioneering the development of a novel class of vaccines, the most advanced of which are next-generation pneumococcal vaccines.

About the company

Status notes
Affinivax was aqcuired by GSK in August 2022.

Exit

Acquisition
2022-08
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy